Loading...
Loading...
Among the 4 tracked institutional investors we monitor, CTXR (CITIUS PHARMACEUTICALS INC) is held with a combined value of $286.62K across 417,289 shares. The largest holder is VANGUARD GROUP INC with a position worth $154.82K. CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$286.62K
Total Shares Held
417,289
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $154.82K | 0.00% | +19.8% |
| 2 | CITADEL ADVISORS LLC | $75.51K | 0.00% | New |
| 3 | BlackRock, Inc. | $42.22K | 0.00% | -0.0% |
| 4 | STATE STREET CORP | $14.07K | 0.00% | - |
SEC Schedule 13D (activist) and 13G (passive) filings for CTXR. Filed when an investor acquires 5%+ ownership.
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CTXR with a position worth $154.82K, representing 0.00% of their portfolio. In total, 4 institutional investors hold CTXR with a combined value of $286.62K.
In the most recent quarter, 1 fund opened a new position in CTXR. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $286.62K worth of CTXR stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $154.82K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CTXR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CTXR positions.
Last Close
$0.40
2026-10-21
YTD
-53.4%
0% of 52-week range